CinCor Pharma, Inc.
CINCDelisted Feb 24, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001868734
CinCor Pharma, Inc. was delisted on Feb 24, 2023; its insiders filed their last Form 4 on Feb 28, 2023; 102 institutions reported holding it in 13F filings for Q4 2022, worth $460.7M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding CinCor Pharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 86 | 102 | +16 |
| Shares | 37.3M | 37.4M | +130.0K (+0.3%) |
| Value | $1.22B | $460.7M | −$762.4M (−62.3%) |
New holders (35)
Institutions that held CinCor Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (19)
Institutions that held CinCor Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| BVF Inc | 1,312,443 | $43.1M |
| Sectoral Asset Management Inc | 195,534 | $6.42M |
| Ensign Peak Advisors, Inc | 78,480 | $2.58M |
| EAM Investors, LLC | 63,839 | $2.10M |
| Integral Health Asset Management, LLC | 50,000 | $1.64M |
| Ikarian Capital, LLC | 45,100 | $1.48M |
| EAM Global Investors LLC | 42,629 | $1.40M |
| Monashee Investment Management LLC | 30,000 | $985.0K |
| Seven Grand Managers, LLC | 20,000 | $656.0K |
| Boothbay Fund Management, LLC | 13,718 | $450.0K |
| SEI Investments Co | 11,850 | $389.0K |
| BNP Paribas Arbitrage, SA | 11,849 | $388.9K |
| Walleye Trading LLC | 8,226 | $270.0K |
| Voya Investment Management LLC | 7,690 | $252.4K |
| State Board of Administration of Florida Retirement System | 7,000 | $230.0K |
| Renaissance Technologies LLC | 7,000 | $230.0K |
| Invesco Ltd. | 6,907 | $227.0K |
| Wells Fargo & Company | 46 | $2.00K |
| Ronald Blue Trust, Inc. | 14 | $0 |